Goldshield Grp (GSD) Quote

AstraZeneca and partner Daiichi Sankyo's experimental drug Dato-DXd was found to extend the lives of some lung cancer patients in a late-stage study. If you want to know more, click on the link to join us https://chat.whatsapp.com/GLbAk15m7R32pMWRiseGfA

AstraZeneca and partner Daiichi Sankyo's experimental drug Dato-DXd was found to extend the lives of some lung cancer patients in a late-stage study. If you want to know more, click on the link to join us https://chat.whatsapp.com/GLbAk15m7R32pMWRiseGfA

AstraZeneca and partner Daiichi Sankyo's experimental drug Dato-DXd was found to extend the lives of some lung cancer patients in a late-stage study. If you want to know more, click on the link to join us https://chat.whatsapp.com/GLbAk15m7R32pMWRiseGfA

The FBI, CIA and DOJ all need a good cleaning from top down to mid managers at least. agree
The GSE's will migrate to a top priority if housing and the economy are destroyed too much by this past administrations policies. If Trump succeeds in getting elected, his cabinet will need to be some

Blow the short rats out of their holes, kill at will hell is where they belong

Look at the chart, history repeats itself, plus look at filings and news. Should see update soon

IFUS made money, good money and wisely got out, though a little early. ASRE got in and set my stop loss and didn’t lose not a penny including fees. Those are the last 2. Made good money in RedHawk SNDD before it turned for the worse ( I got out a little too early and then the CEO put up a stor

AstraZeneca and partner Daiichi Sankyo's experimental drug Dato-DXd was found to extend the lives of some lung cancer patients in a late-stage study. If you want to know more, click the link to join us
https://chat.whatsapp.com/GLbAk15m7R32pMWRiseGfA

Lol. When something looks TOO GOOD TO BE TRUE...it is TOO GOOD TO BE TRUE. only increase greatly in pps is the TRUTH

Major positive reversal in play?

I've been in this for years, and have lost a ton. i'm convinved the company is winner.

"LGHL reported a $5.94 loss per share for FY 2023 recently, which is a great improvement from the $34.97 loss per share in FY 2022."

AstraZeneca and partner Daiichi Sankyo's experimental drug Dato-DXd was found to extend the lives of some lung cancer patients in a late-stage study. If you want to know more, click the link to join us
https://chat.whatsapp.com/GLbAk15m7R32pMWRiseGfA

AstraZeneca and partner Daiichi Sankyo's experimental drug Dato-DXd was found to extend the lives of some lung cancer patients in a late-stage study. If you want to know more, click the link to join us
https://chat.whatsapp.com/GLbAk15m7R32pMWRiseGfA

CATV "unwavering commitment to a future."
Sounds like a new scam in the making.

Most likely that seller has more shares to sell bro. And the same people selling at .19 are trying to swing this from .12 to .20. Just daytraders. Definitely not people IN THE KNOW

STFU. Unlike you, I don't post Bs


PROFESSIONALS FOR )
TRANSPARENCY, )
)
Plaintiff, )
)
v. ) Civil Action No. 4:21-cv-01058-P
) UNITED STATES FOOD AND DRUG ) ADMINISTRATION, )
)
Defendant. )
)
JOINT STATUS R

Well i thought we get a reduction 1:175?

6/4 sit and wait. I’m not calling my broker to sell in expert market. You want out, sell.

Another one done, love it. We’ll see the 8k after EM.

Well what the hell is the delay? 6/2 says deadline

Good post Nuke. I have for a long time now had a hard time to understand some peoples' attitudes towards death. Would think that it is the ultimate example of freedom to be able to choose how we leave this life. I suppose religion has played a role in demonizing the individual's choice in this.

We know you were not even vaguely considered by your own previous admission and you never were in the running because you did not have Glioblastoma or the surgery to remove it.

But your hatred of King's College, it seems really because you have had some serious mental decline, has mad